Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bevacizumab, bleeding, thrombosis, and warfarin.

× No keyword cloud information.

43 in total

Review 1. Neurotoxicity of biologically targeted agents in pediatric cancer trials.

Authors: Elizabeth M Wells; Amulya A Nageswara Rao; Joseph Scafidi; Roger J Packer
Journal: Pediatr Neurol Date: 2012-04 Impact factor: 3.372

2. Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology.

Authors: Em Dietrich; K Antoniades
Journal: Hippokratia Date: 2012-07 Impact factor: 0.471

3. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.

Authors: Sridharan Gururangan; Susan N Chi; Tina Young Poussaint; Arzu Onar-Thomas; Richard J Gilbertson; Sridhar Vajapeyam; Henry S Friedman; Roger J Packer; Brian N Rood; James M Boyett; Larry E Kun
Journal: J Clin Oncol Date: 2010-05-17 Impact factor: 44.544

4. Hemorrhagic events in cancer patients treated with aflibercept: a meta-analysis.

Authors: Ling Peng; Zhibin Bu; Yun Zhou; Xianghua Ye; Junfang Liu; Qiong Zhao
Journal: Tumour Biol Date: 2014-06-24

Review 5. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.

Authors: Hui-Ming Chang; Rohit Moudgil; Tiziano Scarabelli; Tochukwu M Okwuosa; Edward T H Yeh
Journal: J Am Coll Cardiol Date: 2017-11-14 Impact factor: 24.094

Review 6. Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.

Authors: Arvind K Pandey; Eric K Singhi; Juan Pablo Arroyo; Talat Alp Ikizler; Edward R Gould; Jonathan Brown; Joshua A Beckman; David G Harrison; Javid Moslehi
Journal: Hypertension Date: 2017-12-26 Impact factor: 10.190

Review 7. Lessons learned from the bevacizumab experience.

Authors: Joanne Mortimer; Helene B Zonder; Sumanta K Pal
Journal: Cancer Control Date: 2012-10 Impact factor: 3.302

Review 8. Safety of bevacizumab in patients with malignant gliomas: a systematic review.

Authors: G Simonetti; E Trevisan; A Silvani; P Gaviani; A Botturi; E Lamperti; D Beecher; L Bertero; C Bosa; A Salmaggi
Journal: Neurol Sci Date: 2013-11-27 Impact factor: 3.307

9. Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases.

Authors: Matteo Donadon; Jean-Nicolas Vauthey; Evelyne M Loyer; Chusilp Charnsangavej; Eddie K Abdalla
Journal: World J Gastroenterol Date: 2006-10-28 Impact factor: 5.742

Review 10. Epidemiology of cancer-related venous thromboembolism.

Authors: Ted Wun; Richard H White
Journal: Best Pract Res Clin Haematol Date: 2009-03 Impact factor: 3.020